Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
The India GLP-1 analogues market is expected to grow significantly during the forecast period due to the growing middle-class population in countries that are driving increased healthcare spending
JCI Insight 10 , e174825 (2024)
It works by activating the Wnt/beta-catenin signaling pathway, which is crucial for hair follicle development and cycling
The Middle East and Africa held a 2% share of the market in 2025 and are expected to grow at a notable CAGR of 14.8% during the projection period, driven by expanding healthcare investments and obesity management programs
The US Food & Drug Administration has approved only some GLP-1 drugs for weight loss and long-term weight management and only when certain conditions are met
and statements regarding expanded access to treatment options on our platform
US$ 20.14
US$ 25.23
US$ 20.35
US$ 20.83
US$ 21.70
US$ 28.68
